Table 2.
Association between UBC and asthma status, Spain, 1998–2001
| Total | N | Cases, N (%) |
Controls N (%) |
OR* | 95% CI* | P* | OR $ | 95% CI$ | P$ | |
|---|---|---|---|---|---|---|---|---|---|---|
| Asthma | ||||||||||
| No | 1814 | 885 (94.6%) | 929 (90.9%) | 1 | 1 | |||||
| Yes | 144 | 51 (5. 5%) | 93 (9.1%) | 0.56 | 0.39, 0.80 | 0.001 | 0.54 | 0.37, 0.79 | 0.001 | |
| Asthma and /or COPD | ||||||||||
| None | 1647 | 797 (85.1%) | 850 (83.2%) | 1 | 1 | |||||
| Only asthma | 64 | 20 (2.14%) | 44 (4.31%) | 0.48 | 0.28, 0.83 | 0.008 | 0.50 | 0.28, 0.88 | 0.02 | |
| Only COPD | 167 | 88 (9.40%) | 79 (7.73%) | 1.19 | 0.86, 1.63 | 0.40 | 1.07 | 0.76,1.50 | 0.69 | |
| Asthma & COPD | 80 | 31 (3.31%) | 49 (4.79%) | 0.67 | 0.43,1.07 | 0.06 | 0.59 | 0.36,0.96 | 0.03 | |
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; OR, odds ratio; RRR, relative risk ratio; UBC, urothelial bladder cancer.
*
Estimates adjusted by age, gender and region.
$
Estimates adjusted by age, gender, region, smoking status, BMI, fruit consumption (in tertitles), coffee consumption (daily cups of coffee), use of medication/ phenazopyridine to treat UTI